MARKET

DNA

DNA

Ginkgo Bioworks Holdings Inc
NYSE
12.01
-0.36
-2.91%
After Hours: 12.15 +0.14 +1.17% 19:30 11/10 EST
OPEN
12.48
PREV CLOSE
12.37
HIGH
12.73
LOW
11.63
VOLUME
1.47M
TURNOVER
--
52 WEEK HIGH
18.22
52 WEEK LOW
5.37
MARKET CAP
778.55M
P/E (TTM)
-2.3996
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at DNA last week (1102-1106)?
Weekly Report · 1d ago
Ginkgo Bioworks (DNA) Q3 2026 Earnings Call Transcript
The Motley Fool · 4d ago
Ginkgo Bioworks affirms 2026 cash burn target ($150M)-($125M)
TipRanks · 5d ago
Press Release: Ginkgo Bioworks Reports Third Quarter 2026 Results; Signs First Autonomous Lab Sale to a Top-Tier Pharma Company Novo
Dow Jones · 5d ago
Ginkgo Bioworks' Data Partnership Strategy Could Either Validate the Model or Reveal Its Limits
Barchart · 6d ago
Weekly Report: what happened at DNA last week (1026-1030)?
Weekly Report · 11/02 09:29
Ginkgo Bioworks Holdings, Inc. (DNA) Suffers a Larger Drop Than the General Market: Key Insights
NASDAQ · 10/29 21:15
Ginkgo Bioworks Schedules Interactive Third-Quarter 2026 Update
TipRanks · 10/29 20:46
More
About DNA
Ginkgo Bioworks Holdings, Inc. offers biological research and development (R&D) services on its platform and autonomous laboratory to enable its customers to bring their products to market. The Company sells tools and biological R&D services across a range of industries to government and commercial customers. Its in-house autonomous lab is available as Cloud Lab through its Datapoints and Solutions contract research services. Its single segment, namely cell engineering, provides tools and biological R&D services across a range of industries. Its cell engineering customers work with biology to discover and manufacture new products across industries such as medicine, agriculture, industrial biotechnology and government. It provides R&D services spanning genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics. It provides a suite of microservices for product developers across industries that support bioengineers with protein engineering.

Webull offers Ginkgo Bioworks Holdings Inc stock information, including NYSE: DNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DNA stock methods without spending real money on the virtual paper trading platform.